Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (9)
Leukemia (2)
British Journal of Cancer (2)
Nature Immunology (2)
Cancer Gene Therapy (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (13)
Amendments and Corrections (1)
Correspondence (1)
News & Views (1)
Special Features (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biotechnology
Cancer
Diseases
Health care
Immunology
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–17 of 17 results

Advanced filters: Author: D Stroncek Clear advanced filters

Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry

J de la Rubia
C Martínez
MA Sanz
Research30 Sept 1999
Bone Marrow Transplantation

Volume: 24, P: 723-728
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases

EP Alessandrino
P Bernasconi
C Bernasconi
Research05 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 533-537
Author Correction: At the end of the beginning: immunotherapies as living drugs

Ellen G. Feigal
Natalie D. DeWitt
David Stroncek
Amendments and Corrections06 Aug 2019
Nature Immunology

Volume: 20, P: 1405
Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients

K Bochennek
C Andreas
U Koehl
Research25 Jul 2005
Bone Marrow Transplantation

Volume: 36, P: 481-489
WMDA guidelines for subsequent donations following initial BM or PBSCs

D L Confer
B E Shaw
D H Pamphilon
Special Features07 Feb 2011
Bone Marrow Transplantation

Volume: 46, P: 1409-1412
Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism

ANM Wymenga
WTA van der Graaf
NH Mulder
Research20 Oct 1999
Bone Marrow Transplantation

Volume: 24, P: 1015-1018
Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia

Mirazul Islam
Elsa Haniffah Mohamed
Zubaidah Zakaria
ResearchOpen Access12 Sept 2017
British Journal of Cancer

Volume: 117, P: 1551-1556
NAFLD causes selective CD4⁺ T lymphocyte loss and promotes hepatocarcinogenesis

Non-alcoholic fatty liver disease (NAFLD) is shown to promote hepatocellular carcinoma through the generation of linoleic acid, disruption of mitochondrial function and selective loss of CD4⁺ T cells, leading to impaired anti-tumour immunity.

Chi Ma
Aparna H. Kesarwala
Tim F. Greten
Research02 Mar 2016
Nature

Volume: 531, P: 253-257
Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period

Y Katayama
N Mahmut
M Harada
Research23 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 659-665
Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature

R Veerappan
M Morrison
D Variakojis
Research11 Jun 2007
Bone Marrow Transplantation

Volume: 40, P: 361-364
At the end of the beginning: immunotherapies as living drugs

The American Course on Drug Development and Regulatory Science and the US National Institutes of Health held a workshop on cell-based immunotherapy on 22 January 2019.

Ellen G. Feigal
Natalie D. DeWitt
David Stroncek
News & Views15 Jul 2019
Nature Immunology

Volume: 20, P: 955-962
Ex vivo manipulations alter the reconstitution potential of mobilized human CD34⁺ peripheral blood progenitors

L Humeau
R Namikawa
C Chabannon
Research10 Mar 1999
Leukemia

Volume: 13, P: 438-452
Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation

G Socié
JM Cayuela
E Gluckman
Research02 Sept 1998
Leukemia

Volume: 12, P: 1440-1446
CD34⁺ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34⁺ cells mobilized by G-CSF

C Cesana
C Carlo-Stella
V Rizzoli
Research24 Mar 1998
Bone Marrow Transplantation

Volume: 21, P: 561-568
Infusion-related side-effects in children undergoing autologous hematopoietic stem cell transplantation for acute leukemia

P Perseghin
A Balduzzi
C Uderzo
Correspondence07 Jul 2000
Bone Marrow Transplantation

Volume: 26, P: 116-118
Direct T cell–tumour interaction triggers T_H1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme

P Jin
S Civini
D Stroncek
ResearchOpen Access08 May 2014
British Journal of Cancer

Volume: 110, P: 2955-2964
Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells

L Chen
J L Taylor
W J Storkus
Research12 Jul 2013
Cancer Gene Therapy

Volume: 20, P: 469-477

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry

Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases

Author Correction: At the end of the beginning: immunotherapies as living drugs

Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients

WMDA guidelines for subsequent donations following initial BM or PBSCs

Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism

Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia

NAFLD causes selective CD4⁺ T lymphocyte loss and promotes hepatocarcinogenesis

Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period

Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature

At the end of the beginning: immunotherapies as living drugs

Ex vivo manipulations alter the reconstitution potential of mobilized human CD34⁺ peripheral blood progenitors

Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation

CD34⁺ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34⁺ cells mobilized by G-CSF

Infusion-related side-effects in children undergoing autologous hematopoietic stem cell transplantation for acute leukemia

Direct T cell–tumour interaction triggers T_H1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme

Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells

Search

Quick links